News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
752,867 Results
Type
Article (48526)
Company Profile (318)
Press Release (703999)
Multimedia
Podcasts (115)
Webinars (23)
Section
Business (209964)
Career Advice (2217)
Deals (36194)
Drug Delivery (148)
Drug Development (82840)
Employer Resources (197)
FDA (16694)
Job Trends (15383)
News (354333)
Policy (33481)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2783)
Academic (2)
Accelerated approval (45)
Adcomms (29)
Allergies (172)
Alliances (51151)
ALS (211)
Alzheimer's disease (1834)
Antibody-drug conjugate (ADC) (447)
Approvals (17049)
Artificial intelligence (692)
Autoimmune disease (283)
Automation (55)
Bankruptcy (368)
Best Places to Work (11826)
BIOSECURE Act (21)
Biosimilars (221)
Biotechnology (198)
Bladder cancer (187)
Brain cancer (70)
Breast cancer (752)
Cancer (5816)
Cardiovascular disease (473)
Career advice (1889)
Career pathing (46)
CAR-T (338)
CDC (63)
Celiac Disease (3)
Cell therapy (910)
Cervical cancer (47)
Clinical research (71490)
Collaboration (2100)
Company closure (5)
Compensation (1383)
Complete response letters (80)
COVID-19 (2821)
CRISPR (111)
C-suite (1142)
Cystic fibrosis (151)
Data (7774)
Decentralized trials (3)
Denatured (44)
Depression (162)
Dermatology (83)
Diabetes (586)
Diagnostics (7073)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (48)
Drug discovery (333)
Drug pricing (211)
Drug shortages (32)
Duchenne muscular dystrophy (286)
Earnings (92745)
Editorial (70)
Employer branding (25)
Employer resources (167)
Events (122979)
Executive appointments (1110)
FDA (20399)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (34)
Funding (1759)
Gene editing (241)
Generative AI (60)
Gene therapy (731)
GLP-1 (1098)
Government (4897)
Grass and pollen (6)
Guidances (409)
Healthcare (19368)
HIV (81)
Huntington's disease (59)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (98)
Immunology and inflammation (293)
Immuno-oncology (91)
Indications (187)
Infectious disease (3162)
Inflammatory bowel disease (224)
Inflation Reduction Act (16)
Influenza (137)
Intellectual property (293)
Interviews (353)
IPO (16879)
IRA (52)
Job creations (3858)
Job search strategy (1579)
JPM (62)
Kidney cancer (19)
Labor market (107)
Layoffs (589)
Leadership (42)
Legal (8117)
Liver cancer (100)
Longevity (32)
Lung cancer (766)
Lymphoma (428)
Machine learning (61)
Management (63)
Manufacturing (1046)
MASH (188)
Medical device (14080)
Medtech (14193)
Mergers & acquisitions (20557)
Metabolic disorders (1513)
mRNA (208)
Multiple sclerosis (189)
NASH (23)
Neurodegenerative disease (422)
Neuropsychiatric disorders (106)
Neuroscience (3357)
Neurotech (1)
NextGen: Class of 2026 (6726)
Non-profit (4700)
Now hiring (78)
Obesity (716)
Opinion (310)
Ovarian cancer (221)
Pain (257)
Pancreatic cancer (297)
Parkinson's disease (363)
Partnered (35)
Patents (596)
Patient recruitment (666)
Peanut (64)
People (61619)
Pharmaceutical (69)
Pharmacy benefit managers (32)
Phase 1 (22283)
Phase 2 (31476)
Phase 3 (23427)
Pipeline (8404)
Policy (331)
Postmarket research (2648)
Preclinical (9719)
Press Release (72)
Prostate cancer (294)
Psychedelics (57)
Radiopharmaceuticals (325)
Rare diseases (1076)
Real estate (6292)
Recruiting (77)
Regulatory (25827)
Reports (72)
Research institute (2575)
Resumes & cover letters (378)
Rett syndrome (36)
RNA editing (22)
RSV (90)
Schizophrenia (181)
Series A (300)
Series B (216)
Service/supplier (13)
Sickle cell disease (115)
Special edition (26)
Spinal muscular atrophy (168)
Sponsored (49)
Startups (3845)
State (2)
Stomach cancer (19)
Supply chain (129)
Tariffs (87)
The Weekly (69)
Vaccines (1128)
Venture capital (113)
Weight loss (465)
Women's health (125)
Worklife (22)
Date
Today (138)
Last 7 days (935)
Last 30 days (3259)
Last 365 days (30772)
2026 (11908)
2025 (30743)
2024 (35934)
2023 (40856)
2022 (51924)
2021 (56496)
2020 (54897)
2019 (47644)
2018 (35933)
2017 (33084)
2016 (32664)
2015 (38766)
2014 (32375)
2013 (27536)
2012 (29798)
2011 (30536)
2010 (29032)
Location
Africa (817)
Alabama (93)
Alaska (7)
Arizona (357)
Arkansas (15)
Asia (41348)
Australia (6819)
California (13196)
Canada (3747)
China (1335)
Colorado (570)
Connecticut (573)
Delaware (400)
Europe (90537)
Florida (1965)
Georgia (433)
Hawaii (4)
Idaho (63)
Illinois (1062)
India (90)
Indiana (608)
Iowa (24)
Japan (534)
Kansas (133)
Kentucky (52)
Louisiana (41)
Maine (75)
Maryland (1588)
Massachusetts (9500)
Michigan (381)
Minnesota (733)
Mississippi (7)
Missouri (145)
Montana (33)
Nebraska (29)
Nevada (143)
New Hampshire (86)
New Jersey (3502)
New Mexico (31)
New York (3468)
North Carolina (1718)
North Dakota (11)
Northern California (6582)
Ohio (398)
Oklahoma (24)
Oregon (42)
Pennsylvania (2649)
Puerto Rico (29)
Rhode Island (50)
South America (1187)
South Carolina (85)
South Dakota (2)
Southern California (5204)
Tennessee (212)
Texas (2113)
United States (46858)
Utah (397)
Vermont (1)
Virginia (319)
Washington D.C. (85)
Washington State (1062)
West Virginia (4)
Wisconsin (141)
Wyoming (2)
752,867 Results for "kodiak sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2026 Financial Results
May 8, 2026
·
20 min read
Press Releases
Kodiak Sciences to Present Pipeline Advances and KSI-101 Clinical Data, Including Results from a MESI Cohort in a Tertiary Care Uveitis Practice, at Upcoming Scientific Conferences
May 1, 2026
·
14 min read
Press Releases
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
April 1, 2026
·
21 min read
Press Releases
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
January 8, 2026
·
2 min read
Press Releases
Kodiak Sciences Announces Proposed Public Offering of Common Stock
December 16, 2025
·
5 min read
Press Releases
Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham
March 26, 2026
·
21 min read
Press Releases
Kodiak Sciences to Present at Upcoming Investor Conferences - November 12, 2025
November 12, 2025
·
1 min read
Press Releases
Kodiak Sciences Announces Closing of $184 Million Public Offering of Common Stock including Full Exercise of Underwriters’ Option to Purchase Additional Shares
December 19, 2025
·
3 min read
Press Releases
Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2025 Financial Results
November 14, 2025
·
19 min read
Press Releases
Final APEX Phase 1b Clinical Results for Kodiak’s KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026
February 4, 2026
·
4 min read
1 of 75,287
Next
